Ticker Details
Spruce Biosciences, Inc.
IPO Date:	October 9, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$90.57M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 4.55%
Avg Daily Range (30 D):	$2.88 | 4.65%
Avg Daily Range (90 D):	$3.68 | 5.01%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.03M
Avg Daily Volume (90 D):	.03M

Trade Size
Avg Trade Size (Sh.):	199
Avg Trade Size (Sh.) (30 D):	27
Avg Trade Size (Sh.) (90 D):	33

Institutional Trades
Total Institutional Trades:	72
Avg Institutional Trade:	$1.98M
Avg Institutional Trade (30 D):	$1.41M
Avg Institutional Trade (90 D):	$2.7M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.89M
Avg Closing Trade (30 D):	$4M
Avg Closing Trade (90 D):	$4M
Avg Closing Volume:	13.82K

News

Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight

May 13, 2024 @ 9:10 PM Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T... Source: Zacks Equity Research

May 1, 2024 @ 11:55 AM Pfizer (PFE) Q1 Earnings and Revenues Beat Estimat... Source: Zacks Equity Research

Mar 27, 2024 @ 4:00 PM Spruce Biosciences (SPRB) Upgraded to Buy: Here's ... Source: Zacks Equity Research

Mar 21, 2024 @ 2:20 PM Spruce Biosciences (SPRB) Falls 86% in a Month: He... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-50.83	$-9.58	$-50.83
Diluted EPS	$-50.83	$-9.58	$-50.83
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-38.97M	$-14.65M	$-38.97M
Operating Income / Loss	$-36.51M	$-11.1M	$-36.51M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Aug 07, 2025	1:75